131 related articles for article (PubMed ID: 8506118)
1. Induction of complement resistance in cloned pathogenic Entamoeba histolytica.
Hamelmann C; Foerster B; Burchard GD; Shetty N; Horstmann RD
Parasite Immunol; 1993 Apr; 15(4):223-8. PubMed ID: 8506118
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of Entamoeba histolytica and Entamoeba dispar patient isolates to human complement.
Walderich B; Weber A; Knobloch J
Parasite Immunol; 1997 Jun; 19(6):265-71. PubMed ID: 9364556
[TBL] [Abstract][Full Text] [Related]
3. Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysis.
Hamelmann C; Foerster B; Burchard GD; Horstmann RD
Parasite Immunol; 1992 Jan; 14(1):23-35. PubMed ID: 1557228
[TBL] [Abstract][Full Text] [Related]
4. Loss of susceptibility to complement lysis in Entamoeba histolytica HM1 by treatment with human serum.
Calderon J; Tovar R
Immunology; 1986 Jul; 58(3):467-71. PubMed ID: 2874111
[TBL] [Abstract][Full Text] [Related]
5. Complement sensitivity of Entamoeba histolytica and various nonpathogenic amoeba species.
Förster B; Ebert F; Horstmann RD
Trop Med Parasitol; 1994 Dec; 45(4):355-6. PubMed ID: 7716404
[TBL] [Abstract][Full Text] [Related]
6. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
Reed SL; Curd JG; Gigli I; Gillin FD; Braude AI
J Immunol; 1986 Mar; 136(6):2265-70. PubMed ID: 2869084
[TBL] [Abstract][Full Text] [Related]
7. Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).
Hamelmann C; Urban B; Foerster B; Horstmann RD
Infect Immun; 1993 May; 61(5):1636-40. PubMed ID: 8478051
[TBL] [Abstract][Full Text] [Related]
8. Virulence of nonpathogenic zymodemes of Entamoeba histolytica isolates from asymptomatic subjects in Calcutta, India.
Mukherjee RM; Mazumdar M; Maitra TK; Jalan KN
Braz J Med Biol Res; 1992; 25(9):899-903. PubMed ID: 1342835
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose-specific adhesin.
Haque R; Kress K; Wood S; Jackson TF; Lyerly D; Wilkins T; Petri WA
J Infect Dis; 1993 Jan; 167(1):247-9. PubMed ID: 8369019
[TBL] [Abstract][Full Text] [Related]
10. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica.
Tannich E; Horstmann RD; Knobloch J; Arnold HH
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5118-22. PubMed ID: 2544890
[TBL] [Abstract][Full Text] [Related]
11. Resistance to lysis by human serum of pathogenic Entamoeba histolytica.
Reed SL; Sargeaunt PG; Braude AI
Trans R Soc Trop Med Hyg; 1983; 77(2):248-53. PubMed ID: 6306876
[TBL] [Abstract][Full Text] [Related]
12. A novel nested multiplex polymerase chain reaction (PCR) assay for differential detection of Entamoeba histolytica, E. moshkovskii and E. dispar DNA in stool samples.
Khairnar K; Parija SC
BMC Microbiol; 2007 May; 7():47. PubMed ID: 17524135
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay based on monoclonal and polyclonal antibodies for the detection of Entamoeba histolytica antigens in faecal specimens.
Wonsit R; Thammapalerd N; Tharavanij S; Radomyos P; Bunnag D
Trans R Soc Trop Med Hyg; 1992; 86(2):166-9. PubMed ID: 1440778
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an immuno-dominant variable surface antigen from pathogenic and nonpathogenic Entamoeba histolytica.
Edman U; Meraz MA; Rausser S; Agabian N; Meza I
J Exp Med; 1990 Sep; 172(3):879-88. PubMed ID: 1696956
[TBL] [Abstract][Full Text] [Related]
15. Virulence of Entamoeba histolytica correlates with the capacity to develop complement resistance.
Mogyoros M; Calef E; Gitler C
Isr J Med Sci; 1986 Dec; 22(12):915-7. PubMed ID: 2883155
[No Abstract] [Full Text] [Related]
16. An immunogenic 30-kDa surface antigen of pathogenic clinical isolates of Entamoeba histolytica.
Blakely P; Sargeaunt PG; Reed SL
J Infect Dis; 1990 Oct; 162(4):949-54. PubMed ID: 2205653
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of amoebiasis in a model research community and its confirmation using stool antigen elisa for Entamoeba histolytica.
Akhtar T; Khan AG; Ahmed I; Nazli R; Haider J
Pak J Pharm Sci; 2016 Sep; 29(5):1587-1590. PubMed ID: 27731816
[TBL] [Abstract][Full Text] [Related]
18. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
Calderon J; Schreiber RD
Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
[TBL] [Abstract][Full Text] [Related]
19. Short report: detection of Entamoeba histolytica and E. dispar directly in stool.
Haque R; Neville LM; Wood S; Petri WA
Am J Trop Med Hyg; 1994 May; 50(5):595-6. PubMed ID: 7515594
[TBL] [Abstract][Full Text] [Related]
20. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes.
Burchard GD; Mirelman D
Exp Parasitol; 1988 Aug; 66(2):231-42. PubMed ID: 2899517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
